Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Amgen
AMGN
|
$1.12B |
| 2 |
Exxon Mobil
XOM
|
$967M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$945M |
| 4 |
T-Mobile US
TMUS
|
$657M |
| 5 |
American International
AIG
|
$608M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.51B |
| 2 |
Gilead Sciences
GILD
|
$1.32B |
| 3 |
DuPont de Nemours
DD
|
$1.08B |
| 4 |
General Motors
GM
|
$739M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
$664M |
Sector Composition
| 1 | Healthcare | 20.83% |
| 2 | Technology | 12.2% |
| 3 | Industrials | 11.56% |
| 4 | Communication Services | 11.27% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $10.2B | 3.79% | 136,067,270 -17,621,556 | -11% | -$1.32B |
|
|
2
Amgen
AMGN
$155B
| $8.84B | 3.27% | 77,432,460 +9,832,857 | +15% | +$1.12B |
|
3
Philip Morris
PM
$260B
| $8.5B | 3.15% | 97,570,982 -4,603,830 | -5% | -$401M |
|
|
4
Alphabet (Google) Class C
GOOG
$2.58T
| $8B | 2.96% | 7,137,097 +843,503 | +13% | +$945M |
|
5
Oracle
ORCL
$635B
| $5.87B | 2.17% | 153,549,331 +5,399,031 | +4% | +$207M |
|
6
Amazon
AMZN
$2.44T
| $5.72B | 2.12% | 14,347,890 +80,090 | +0.6% | +$31.9M |
|
7
Altria Group
MO
$113B
| $5.65B | 2.09% | 147,140,635 -4,015,740 | -3% | -$154M |
|
8
AbbVie
ABBV
$372B
| $5.28B | 1.95% | 99,962,125 -4,818,713 | -5% | -$254M |
|
9
Verizon
VZ
$186B
| $4.88B | 1.8% | 99,218,160 -5,798,000 | -6% | -$285M |
|
10
Texas Instruments
TXN
$184B
| $4.32B | 1.6% | 98,294,972 +5,398,661 | +6% | +$237M |
|
11
Home Depot
HD
$405B
| $3.57B | 1.32% | 43,396,840 -1,958,658 | -4% | -$161M |
|
12
General Dynamics
GD
$87.3B
| $3.4B | 1.26% | 35,552,979 +2,194,279 | +7% | +$210M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.15B | 1.17% | 23,703,112 +1,498,586 | +7% | +$199M |
|
|
14
Microsoft
MSFT
$3.77T
| $3.15B | 1.17% | 84,227,160 -67,040,849 | -44% | -$2.51B |
|
15
EOG Resources
EOG
$68.2B
| $3.01B | 1.11% | 17,924,494 -2,875,759 | -14% | -$483M |
|
16
Schlumberger
SLB
$55B
| $2.86B | 1.06% | 31,743,089 -2,499,250 | -7% | -$225M |
|
17
UnitedHealth
UNH
$281B
| $2.81B | 1.04% | 37,303,623 +2,291,300 | +7% | +$173M |
|
18
Johnson Controls International
JCI
$69.9B
| $2.72B | 1.01% | 52,929,119 -607,080 | -1% | -$31.1M |
|
19
Accenture
ACN
$162B
| $2.57B | 0.95% | 31,298,820 +2,178,554 | +7% | +$179M |
|
20
Biogen
BIIB
$19.4B
| $2.56B | 0.95% | 9,157,000 +315,000 | +4% | +$88.1M |
|
21
CSX Corp
CSX
$60.6B
| $2.52B | 0.93% | 87,716,051 -13,496,785 | -13% | -$388M |
|
|
22
DuPont de Nemours
DD
$32.2B
| $2.51B | 0.93% | 56,596,633 -24,257,030 | -30% | -$1.08B |
|
23
Union Pacific
UNP
$133B
| $2.5B | 0.92% | 14,853,557 -396,570 | -3% | -$66.6M |
|
24
Comcast
CMCSA
$125B
| $2.48B | 0.92% | 47,712,600 -2,475,788 | -5% | -$129M |
|
25
United Parcel Service
UPS
$74.1B
| $2.34B | 0.87% | 22,251,740 -145,860 | -0.7% | -$15.3M |
|